LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424
Study has demonstrated the abnormal expression and role of lncRNA CASC15 in diabetes patients with chronic renal failure. However, its role in diabetes nephropathy (DN) is still unclear. This study aimed to investigate the potential mechanism and role of lncRNA CASC15 in DN. The relationship between...
Main Authors: | Li Hui, Hao Jian, Yu Weimin |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2023-07-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2023-0710 |
Similar Items
-
LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p
by: Jingjing Yao, et al.
Published: (2021-07-01) -
Lncrna CASC11 aggravates diabetic nephropathy via targeting FoxO1
by: Zhang Yun, et al.
Published: (2023-01-01) -
Altered expression of serum lncRNA CASC2 and miRNA-21-5p in COVID-19 patients
by: Shymaa E. Ayoub, et al.
Published: (2024-02-01) -
Association between lncRNA CASC8 polymorphisms and the risk of cancer: a meta-analysis
by: Cui Z, et al.
Published: (2018-08-01) -
LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway
by: Wenchan Hsu, et al.
Published: (2019-06-01)